Gemmus Pharma Alternatives & Competitors

6 companies similar to Gemmus Pharma — Pioneering new horizons in influenza treatment with innovative cardiovascular so...

Affymax

Pioneering innovative therapies for life-threatening conditions, aiming to enhance anemia...

51-200 Venture round $173.00M

Biopharma Biotechnology +1

Sen-Jam Pharmaceutical

We’re changing the way the world treats inflammation and the way the pharma industry treat...

12 Seed

Biotechnology Health Care +1

QRxPharma

Pioneering pain management with innovative products and advanced abuse prevention technolo...

Post-IPO Equity $34.50M

Biopharma Biotechnology +1

InfectoPharm Arzneimittel und Consilium GmbH

InfectoPharm ist ein mittelständischer Arzneimittelhersteller in zweiter Generation mit Wu...

173

Heppenheim, Germany

Health Care Medical Devices +1

Track all Gemmus Pharma competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Panolos Bioscience

Frontrunner in structure-based protein design and development. Focused on multi-specific b...

7 Series A $20.00B

Hwaseong-si, Korea South

Biopharma Biotechnology +1

Welmedix Consumer Healthcare

Innovative healthcare solutions enhancing well-being since 2005, based in Princeton, New J...

Venture round $8.09M

Biotechnology Health Care +2

About Gemmus Pharma

Gemmus Pharma, established in 2007, focuses on commercializing licensed technology from a prominent pharmaceutical firm. Their primary candidate is a cardiovascular drug, commonly used in Asia, now being adapted for influenza treatment. Supported by the National Institute of Allergy and Infectious Disease (NIAID), Gemm...

Business keywords

Pharmaceuticals, Drug Development, Cardiovascular Solutions, Innovative Treatment, Influenza, Series A Funding, FDA Regulation, Investigational New Drug Application, National Institute Of Allergy And Infectious Disease, Asia Market, License Technology, Startup, Investment

Frequently Asked Questions

Companies similar to Gemmus Pharma include Affymax, Sen-Jam Pharmaceutical, QRxPharma, InfectoPharm Arzneimittel und Consilium GmbH, Panolos Bioscience. They work in Biotechnology and Health Care and share Gemmus Pharma's focus on drug development, pharmaceuticals and fda regulation.

Bounce Watch lists 6 companies that share Gemmus Pharma's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Gemmus Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Gemmus Pharma Profile Affymax Alternatives Sen-Jam Pharmaceutical Alternatives QRxPharma Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Gemmus Pharma on 12 Sep 2024. The 6 companies listed here were last checked between 21 Jun 2024 and 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.